| P2093 | author name string | Hideyuki Ishida | |
| | Keiichiro Ishibashi | |
| | Erito Mochiki | |
| | Hiroyuki Kuwano | |
| | Minoru Fukuchi | |
| | Okihide Suzuki | |
| | Toru Ishiguro | |
| | Youichi Kumagai | |
| | Kyoichi Ogata | |
| P2860 | cites work | Global cancer statistics | Q22241238 |
| | 5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer | Q33487198 |
| | A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis | Q33656736 |
| | Epidemiology of gastric cancer | Q33788193 |
| | S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial | Q34588472 |
| | Phase II multi-institutional prospective randomised trial comparing S-1+paclitaxel with S-1+cisplatin in patients with unresectable and/or recurrent advanced gastric cancer | Q36075265 |
| | Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer | Q36673543 |
| | The roles of surgical oncologists in the new era: minimally invasive surgery for early gastric cancer and adjuvant surgery for metastatic gastric cancer | Q37959113 |
| | Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205). | Q40613157 |
| | Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination | Q43272228 |
| | Japanese gastric cancer treatment guidelines 2010 (ver. 3). | Q51568719 |
| P433 | issue | 11 | |
| P304 | page(s) | 3618-3624 | |
| P577 | publication date | 2015-02-07 | |
| P1433 | published in | Annals of Surgical Oncology | Q2853069 |
| P1476 | title | Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer. | |
| P478 | volume | 22 | |